ResearcherNational Institutes of HealthNo recent work listed

Nebojša Skorupan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0854-3360; OpenAlex author ID A5074974337. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2022: 2 papers

Papers 2

Low serum mesothelin in pancreatic cancer patients results from retention of shed mesothelin in the tumor microenvironment. Co-author DOI 10.1016/j.tranon.2022.101440 ↗
Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers14174209 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Christine Alewine · 2 shared papers, 2022 · strength 0.40
- Paper Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers14174209 ↗
- Paper Low serum mesothelin in pancreatic cancer patients results from retention of shed mesothelin in the tumor microenvironm… DOI 10.1016/j.tranon.2022.101440 ↗
Xianyu Zhang · 1 shared paper, 2022 · strength 0.17
- Paper Low serum mesothelin in pancreatic cancer patients results from retention of shed mesothelin in the tumor microenvironm… DOI 10.1016/j.tranon.2022.101440 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.